Growth Metrics

Quest Diagnostics (DGX) Other Operating Expenses (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Other Operating Expenses for 17 consecutive years, with $17.0 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 183.33% to $17.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.0 million through Dec 2025, up 1300.0% year-over-year, with the annual reading at $12.0 million for FY2025, 1300.0% up from the prior year.
  • Other Operating Expenses hit $17.0 million in Q4 2025 for Quest Diagnostics, up from -$23.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $20.0 million in Q2 2025 to a low of -$35.0 million in Q4 2023.
  • Historically, Other Operating Expenses has averaged -$2.6 million across 5 years, with a median of -$2.0 million in 2024.
  • Biggest YoY gain for Other Operating Expenses was 600.0% in 2025; the steepest drop was 2200.0% in 2025.
  • Year by year, Other Operating Expenses stood at $2.0 million in 2021, then tumbled by 1150.0% to -$21.0 million in 2022, then plummeted by 66.67% to -$35.0 million in 2023, then soared by 117.14% to $6.0 million in 2024, then skyrocketed by 183.33% to $17.0 million in 2025.
  • Business Quant data shows Other Operating Expenses for DGX at $17.0 million in Q4 2025, -$23.0 million in Q3 2025, and $20.0 million in Q2 2025.